Literature DB >> 15043192

Opg, RANKl, and RANK in cancer metastasis: expression and regulation.

Julie M Brown1, Jian Zhang, Evan T Keller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15043192     DOI： 10.1007/978-1-4419-9129-4_7

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  13 in total

1.  Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo.

Authors:  Yen-Tung A Teng; Deeqa Mahamed; Bhagirath Singh
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 2.  Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists.

Authors:  Christopher W Cutler; Yen-Tung A Teng
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

Review 3.  Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Authors:  Ali Cekici; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

4.  Interleukin-10 inhibits gram-negative-microbe-specific human receptor activator of NF-kappaB ligand-positive CD4+-Th1-cell-associated alveolar bone loss in vivo.

Authors:  Xiaoxia Zhang; Yen-Tung A Teng
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  TAp63 regulates bone remodeling by modulating the expression of TNFRSF11B/Osteoprotegerin.

Authors:  Anna Maria Lena; Erica Foffi; Massimiliano Agostini; Mara Mancini; Margherita Annicchiarico-Petruzzelli; Daniel Aberdam; Tania Velletri; Yufang Shi; Gerry Melino; Ying Wang; Eleonora Candi
Journal:  Cell Cycle       Date:  2021-11-11       Impact factor: 4.534

6.  Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.

Authors:  Mandeep S Virk; Frank A Petrigliano; Nancy Q Liu; Arion F Chatziioannou; David Stout; Christine O Kang; William C Dougall; Jay R Lieberman
Journal:  Bone       Date:  2008-09-26       Impact factor: 4.398

7.  Oral inflammatory diseases and systemic inflammation: role of the macrophage.

Authors:  Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Front Immunol       Date:  2012-05-16       Impact factor: 7.561

8.  Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines.

Authors:  Vivian Labovsky; Valeria B Fernández Vallone; Leandro M Martinez; Julian Otaegui; Norma A Chasseing
Journal:  Cancer Cell Int       Date:  2012-06-18       Impact factor: 5.722

9.  Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.

Authors:  Daniele Santini; Gaia Schiavon; Bruno Vincenzi; Laura Gaeta; Francesco Pantano; Antonio Russo; Cinzia Ortega; Camillo Porta; Sara Galluzzo; Grazia Armento; Nicla La Verde; Cinzia Caroti; Isabelle Treilleux; Alessandro Ruggiero; Giuseppe Perrone; Raffaele Addeo; Philippe Clezardin; Andrea Onetti Muda; Giuseppe Tonini
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  CXCL12-γ in primary tumors drives breast cancer metastasis.

Authors:  P Ray; A C Stacer; J Fenner; S P Cavnar; K Meguiar; M Brown; K E Luker; G D Luker
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.